Go overweight on pharma; buy midcap IT basket, tier II PSU banks now: Dipan Mehta
Pharma stocks are currently seen as a strong investment due to robust earnings potential. Midcap IT stocks are outperforming their largecap counterparts. L&T’s entry into the power equipment sector might increase competition. FMCG sector growth appears slow, but niche categories may offer opportunities. Tier II PSU banks are also showing potential despite higher valuations.
